JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, L.
Right arrow Articles by Goetzl, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, L.
Right arrow Articles by Goetzl, E. J.

Vol. 286, Issue 3, 1420-1426, September 1998

EP4/EP2 Receptor-Specific Prostaglandin E2 Regulation of Interleukin-6 Generation by Human HSB.2 Early T Cells1

Li Zeng, Songzhu An and Edward J. Goetzl

Departments of Medicine and Microbiology-Immunology, University of California Medical Center, San Francisco, California

Human leukemic early T cells of the HSB.2 line coexpress the EP2, EP3 and EP4 subtypes of prostaglandin E2 (PGE2) receptors (Rs). EP3 Rs have previously been demonstrated to transduce PGE2 stimulation of secretion of matrix metalloproteinase (MMP)-9 by HSB.2 T cells through Ca++-dependent enhancement of MMP-9 mRNA transcription. We now show that PGE2 and the EP4/EP2/EP3 R-selective agonist misoprostol, but not the EP3 R-directed agonists sulprostone and M&B28767, induced increases in HSB.2 T cell interleukin-6 (IL-6) mRNA and secretion. Pharmacological agents that increase intracellular concentration of cyclic AMP ([cAMP]i) mimicked and synergistically enhanced induction of IL-6 secretion by PGE2, whereas inhibitors of protein kinase A (PKA) but not protein kinase C suppressed PGE2-evoked increases in IL-6 secretion, suggesting that cAMP and PKA are the intracellular messengers of the PGE2 effect. Exposure of HSB.2 T cells to the mitogenic lectin concanavalin A (Con A) increased basal IL-6 secretion, without a change in IL-6 mRNA level. Con A-stimulated HSB.2 T cells responded to PGE2 with greater increases in IL-6 mRNA and secretion of IL-6. Con A also down-regulated mRNA encoding both EP3 Rs and EP2 Rs, and concurrently up-regulated mRNA encoding EP4 Rs of HSB.2 T cells. Therefore, EP4 and EP2 Rs mediate PGE2-induced increases in IL-6 secretion by HSB.2 T cells through a transcriptional and cAMP dependent-mechanism. The increased ratio of EP4 Rs/EP3 Rs may contribute to Con A enhancement of PGE2-elicited increases in IL-6 secretion by HSB.2 T cells.

0022-3565/98/2863-1420$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Immunol.Home page
B.-C. Chen, C.-C. Liao, M.-J. Hsu, Y.-T. Liao, C.-C. Lin, J.-R. Sheu, and C.-H. Lin
Peptidoglycan-Induced IL-6 Production in RAW 264.7 Macrophages Is Mediated by Cyclooxygenase-2, PGE2/PGE4 Receptors, Protein Kinase A, I{kappa}B Kinase, and NF-{kappa}B
J. Immunol., July 1, 2006; 177(1): 681 - 693.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. Akaogi, H. Yamada, Y. Kuroda, D. C. Nacionales, W. H. Reeves, and M. Satoh
Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-{alpha} and IL-6 production
J. Leukoc. Biol., July 1, 2004; 76(1): 227 - 236.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Walch, E. Clavarino, and P. L. Morris
Prostaglandin (PG) FP and EP1 Receptors Mediate PGF2{alpha} and PGE2 Regulation of Interleukin-1{beta} Expression in Leydig Cell Progenitors
Endocrinology, April 1, 2003; 144(4): 1284 - 1291.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. O. Yarovinsky and G. W. Hunninghake
Lung fibroblasts inhibit activation-induced death of T cells through PGE2-dependent mechanisms
Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1248 - L1256.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Yoshida, H. Sakamoto, T. Horiuchi, S. Yamamoto, A. Suematsu, H. Oda, and Y. Koshihara
Involvement of Prostaglandin E2 in Interleukin-1{{alpha}}-Induced Parathyroid Hormone-Related Peptide Production in Synovial Fibroblasts of Patients with Rheumatoid Arthritis
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3272 - 3278.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Tavakoli, M. J. Cowan, T. Benfield, C. Logun, and J. H. Shelhamer
Prostaglandin E2-induced interleukin-6 release by a human airway epithelial cell line
Am J Physiol Lung Cell Mol Physiol, January 1, 2001; 280(1): L127 - L133.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Gomi, F.-G. Zhu, and J. S. Marshall
Prostaglandin E2 Selectively Enhances the IgE-Mediated Production of IL-6 and Granulocyte-Macrophage Colony-Stimulating Factor by Mast Cells Through an EP1/EP3-Dependent Mechanism
J. Immunol., December 1, 2000; 165(11): 6545 - 6552.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.